The purpose of the ‘Medication Safety Watch’ newsletter is to provide timely information about medicine-related incidents, errors and adverse drug reactions, their implications and offers recommendations on how to improve medication safety.
This is an output from the medication safety expert advisory group (EAG) and is put together by the Commission’s medication safety specialists. Medication Safety Watch replaces the former DHB Safe and Quality Use of Medicines (SQM) group newsletter.
This newsletter complements the other newsletters/factsheets released by the Commission e.g. Medication Safety factsheet, which describes projects under the Commission’s medication safety programme and the Medication Safety Programme newsletter, which details progress on the current projects.